Tin tức & Cập nhật
Lọc theo Chuyên ngành:

Glecaprevir/pibrentasvir shows favourable efficacy signals for paediatric HCV
10 Jul 2024
bởiAudrey Abella
Findings from the ongoing POLAC project demonstrate that treatment with the pangenotypic regimen comprising glecaprevir/pibrentasvir (GLE/PIB) for 8 weeks is highly effective against chronic hepatitis C virus (HCV) infection in children and adolescents. This regimen also showed a good safety profile.
Glecaprevir/pibrentasvir shows favourable efficacy signals for paediatric HCV
10 Jul 2024
Antibiotics may promote development of Kawasaki disease
28 Jun 2024
Use of antibiotics appears to increase the risk of Kawasaki disease (KD) in children, reveals a study. KD development is potentially driven by gut microbiota changes due to antibiotic use.